Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
about
Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiencyMecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEXGrowth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b geneLongitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safetyGrowth hormone, IGF-I and insulin and their abuse in sport.Interactions between vitamin D and IGF-I: from physiology to clinical practice.Doping in sport: effects, harm and misconceptions.Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophyA pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infantsOpen-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.Insulin-like growth factor-I (rhIGF-I) therapy of short stature.Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies.Growth hormone insensitivity: diagnostic and therapeutic approaches.Effects of the IGF-I/IGFBP-3 complex on GH and ghrelin nocturnal concentrations in low birth weight children.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Effect of insulin-like growth factor-I during the early postnatal period in intrauterine growth-restricted rats.
P2860
Q24654465-623200E3-CE71-45D9-B536-17848726A7D2Q28273812-FAEFF1DD-96A4-4464-A10B-D0A3704875DFQ28295216-8C1567CC-66F8-4034-BEAD-CB83548E0A84Q33640027-A3752A2B-B472-4DBA-9829-C160F2B9B042Q34010760-21F91010-B941-491C-9A0E-7D9A819E2902Q34352477-017F1A3F-87AB-4B09-BCD2-D801F2BD2F20Q34446275-098F787B-FB39-421C-B741-D4C8CC1F7721Q34642189-CA406B53-C8F6-4BC1-A3EF-31191D65066BQ35800245-0F6168C0-2BF1-4AFA-9A70-A6F01F85D29EQ36031200-19098ED0-9CCF-413B-AF2B-8F5AFCD86D7CQ37192175-FC9940F9-FCED-4435-8965-9F892D61CBABQ37810155-8379DB35-11C7-4C30-9891-ED8A1C90F074Q38524183-50530298-73CC-49E3-8CF5-4C7DC1506441Q47316770-0555D672-6F82-493A-9738-5F5EF87F6F5FQ47568034-390B9CC7-2987-4A18-8421-32B382273172Q52145506-E2323363-F4E4-47E5-BE91-758B47C7AE73
P2860
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacokinetic studies of rec ...... ormone insensitivity syndrome.
@en
Pharmacokinetic studies of recombinant human insulin-like growth factor I
@nl
type
label
Pharmacokinetic studies of rec ...... ormone insensitivity syndrome.
@en
Pharmacokinetic studies of recombinant human insulin-like growth factor I
@nl
prefLabel
Pharmacokinetic studies of rec ...... ormone insensitivity syndrome.
@en
Pharmacokinetic studies of recombinant human insulin-like growth factor I
@nl
P2093
P356
P1476
Pharmacokinetic studies of rec ...... ormone insensitivity syndrome.
@en
P2093
Alan Rogol
Andreas Sommer
Cecilia Camacho-Hübner
Farideh Miraki-Moud
Francesco Minuto
Geoffrey Allan
Helen L Storr
Jan Frystyk
Mark Sleevi
Martin O Savage
P304
P356
10.1210/JC.2005-1017
P407
P577
2006-01-10T00:00:00Z